Gene encoding a deubiquitinating enzyme is mutated in artesunate‐ and chloroquine‐resistant rodent malaria parasites §

Abstract

Summary Artemisinin‐ and artesunate‐resistant Plasmodium chabaudi mutants, AS‐ART and AS‐ATN, were previously selected from chloroquine‐resistant clones AS‐30CQ and AS‐15CQ respectively. Now, a genetic cross between AS‐ART and the artemisinin‐sensitive clone AJ has been analysed by Linkage Group Selection. A genetic linkage group on chromosome 2 was selected under artemisinin treatment. Within this locus, we identified two different mutations in a gene encoding a deubiquitinating enzyme. A distinct mutation occurred in each of the clones AS‐30CQ and AS‐ATN, relative to their respective progenitors in the AS lineage. The mutations occurred independently in different clones under drug selection with chloroquine (high concentration) or artesunate. Each mutation maps to a critical residue in a homologous human deubiquitinating protein structure. Although one mutation could theoretically account for the resistance of AS‐ATN to artemisinin derivates, the other cannot account solely for the resistance of AS‐ART, relative to the responses of its sensitive progenitor AS‐30CQ. Two lines of Plasmodium falciparum with decreased susceptibility to artemisinin were also selected. Their drug‐response phenotype was not genetically stable. No mutations in the UBP‐1 gene encoding the P. falciparum orthologue of the deubiquitinating enzyme were observed. The possible significance of these mutations in parasite responses to chloroquine or artemisinin is discussed.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 52

1. 1.

   Afonso A, Hunt P, Cheesman S, Alves CA, Cunha CV, do Rosario V, Cravo P. Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+-ATPase), tctp, mdr1, and cg10. Antimicrob Agents Chemother. 2006;50:480-489.

   Not in our library10.1128/aac.50.2.480-489.2006

2. 2.

   Becker K, Tilley L, Vennerstrom JL, Roberts D, Rogerson S, Ginsburg H. Oxidative stress in malaria parasite-infected erythrocytes: host–parasite interactions. Int J Parasitol. 2004;34:163-189.

   Not in our library10.1016/j.ijpara.2003.09.011

3. 3.

   Bhisutthibhan J, Pan XQ, Hossler PA, Walker DJ, Yowel CA, Carlton J, et al. The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. J Biol Chem. 1998;273:16192-16198.

   Not in our library10.1074/jbc.273.26.16192

4. 4.

   Carlton J, Mackinnon M, Walliker D. A chloroquine-resistance locus in the rodent malaria parasite Plasmodium chabaudi. Mol Biochem Parasitol. 1998;93:57-72.

   Not in our library10.1016/s0166-6851(98)00021-8

5. 5.

   Carlton J, Hayton K, Cravo P, Walliker D. of mice and malaria mutants: unravelling the genetics of drug resistance using rodent malaria models. Trends Parasitol. 2001;17:236-242.

   Not in our library10.1016/s1471-4922(01)01899-2

6. 6.

   Carter R, Hunt P, Cheesman S. Linkage Group Selection – a fast approach to the genetic analysis of malaria parasites. Int J Parasitol. 2007;37:285-293.

   Not in our library10.1016/j.ijpara.2006.11.013

7. 7.

   Cheesman S, Creasey A, Degnan K, Afonso A, Cravo P, Hunt P. Validation of Pyrosequencing for accurate and high throughput estimation of allele frequencies in malaria parasites. Mol Biochem Parasitol. 2007;152:213-219.

   Not in our library10.1016/j.molbiopara.2006.12.008

8. 8.

   Cravo PVL, Carlton JM-R, Hunt P, Bisoni L, Padua RA, Walliker D. Genetics of mefloquine resistance in the rodent malaria Plasmodium chabaudi. Antimicrob Agents Chemother. 2003;47:709-718.

   Not in our library10.1128/aac.47.2.709-718.2003

9. 9.

   Culleton R, Martinelli A, Hunt P, Carter R. Linkage group selection: rapid gene discovery in malaria parasites. Genome Res. 2005;15:92-97.

   Not in our library10.1101/gr.2866205

10. 10.

    Delano WL. 2002.

    Not in our library

11. 11.

    Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979;16:710-718.

    Not in our library10.1128/aac.16.6.710

12. 12.

    Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature. 2003;424:957-961.

    Not in our library10.1038/nature01813

13. 13.

    Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Cryst D. 2004;60:2126-2132.

    Not in our library10.1107/s0907444904019158

14. 14.

    Ferrer-Rodríguez I, Pérez-Rosado J, Gervais GW, Peters W, Robinson BL, Serrano AE. Plasmodium yoelii: identification and partial characterization of an mdr1 gene in an artemisinin-resistant line. J Parasitol. 2004;90:152-160.

    Not in our library10.1645/ge-3225

15. 15.

    Grech K, Martinelli A, Pathirana S, Walliker D, Hunt P, Carter R. Numerous, robust genetic markers for Plasmodium chabaudi by the method of amplified fragment length polymorphism. Mol Biochem Parasitol. 2002;123:95-104.

    Not in our library10.1016/s0166-6851(02)00142-1

16. 16.

    Hayton K, Ranford-Cartwright L, Walliker D. Sulfadoxine-pyrimethamine resistance in the rodent malaria parasite Plasmodium chabaudi. Antimicrob Agents Chemother. 2002;46:2482-2489.

    Not in our library10.1128/aac.46.8.2482-2489.2002

17. 17.

    Hu M, Li P, Li M, Li W, Yao T, Wu J-W, et al. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell. 2002;111:1041-1054.

    Not in our library10.1016/s0092-8674(02)01199-6

18. 18.

    Huang T, D'Andrea A. Regulation of DNA repair by ubiquitylation. Nat Rev Mol Cell Biol. 2006;7:323-334.

    Not in our library10.1038/nrm1908

19. 19.

    Hunt P, Cravo P, Donleavy P, Carlton J, Walliker D. Chloroquine resistance in Plasmodium chabaudi: are chloroquine-resistance transporter (crt) and multi-drug resistance (mdr1) orthologues involved? Mol Biochem Parasitol. 2004a;133:27-35.

    Not in our library10.1016/j.molbiopara.2003.08.010

20. 20.

    Hunt P, Martinelli A, Fawcett R, Carlton J, Carter R, Walliker D. Gene synteny and chloroquine resistance in Plasmodium chabaudi. Mol Biochem Parasitol. 2004b;136:157-164.

    Not in our library10.1016/j.molbiopara.2004.03.008

21. 21.

    Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, et al. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet. 2005;366:1960-1963.

    Not in our library10.1016/s0140-6736(05)67787-2

22. 22.

    Karcz S, Hermann V, Trottein F, Cowman A. Cloning and characterisation of the vacuolar ATPase B subunit from Plasmodium falciparum. Mol Biochem Parasitol. 1994;65:123-133.

    Not in our library10.1016/0166-6851(94)90121-x

23. 23.
    A Plasmodium Whole-Genome Synteny Map: Indels and Synteny Breakpoints as Foci for Species-Specific Genes · 2005

    No notice
24. 24.

    Krishna S, Woodrow CJ, Staines HM, Haynes RK, Mercereau-Puijalon O. Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance. Trends Mol Med. 2006;12:200-205.

    Not in our library10.1016/j.molmed.2006.03.005

25. 25.

    Krungkrai S, Yuthavong Y. The antimalarial action on Plasmodium falciparum of qinghaosu and artesunate in combination with agents which modulate oxidant stress. Trans R Soc Trop Med Hyg. 1987;81:710-714.

    Not in our library10.1016/0035-9203(87)90003-4

26. 26.

    Landau I. Description of Plasmodium chabaudi, parasite of african rodents. C R Acad Sci Hebd Seances Acad Sci D. 1965;260:3758-3761.

    Not in our library

27. 27.

    Landau I, Chabaud AG. Natural infection by 2 plasmodia of the rodent Thamnomys rutilans in the Central African Republic. C R Acad Sci Hebd Seances Acad Sci D. 1965;261:230-232.

    Not in our library

28. 28.
    Yeast Model Uncovers Dual Roles of Mitochondria in the Action of Artemisinin · 2005

    No notice
29. 29.

    Martinelli A, Hunt P, Cheesman S, Carter R. Amplified fragment length polymorphism measures proportions of malaria parasites carrying specific alleles in complex genetic mixtures. Mol Biochem Parasitol. 2004;136:117-122.

    Not in our library10.1016/j.molbiopara.2004.02.011

30. 30.

    Martinelli A, Cheesman S, Hunt P, Culleton R, Raza A, Mackinnon M, Carter R. A genetic approach to the de novo identification of targets of strain-specific immunity in malaria parasites. Proc Natl Acad Sci USA. 2005a;102:814-819.

    Not in our library10.1073/pnas.0405097102

31. 31.

    Martinelli A, Hunt P, Fawcett R, Cravo P, Walliker D, Carter R. An AFLP-based Genetic Linkage Map of Plasmodium chabaudi chabaudi. Malar J. 2005b;4:11-20.

    Not in our library10.1186/1475-2875-4-11

32. 32.

    Meshnick SR. Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol. 2002;32:1655-1660.

    Not in our library10.1016/s0020-7519(02)00194-7

33. 33.

    Meshnick SR, Thomas A, Ranz A, Xu CM, Pan HZ. Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. Mol Biochem Parasitol. 1991;49:181-189.

    Not in our library10.1016/0166-6851(91)90062-b

34. 34.

    Murakami K, Tanabe K, Takada S. Structure of a Plasmodium yoelii gene-encoded protein homologous to the Ca2+-ATPase of rabbit skeletal muscle sarcoplasmic reticulum. J Cell Sci. 1990;97:487-495.

    Not in our library10.1242/jcs.97.3.487

35. 35.

    Olliaro PL, Haynes RK, Meunier B, Yuthavong Y. Possible modes of action of the artemisinin-type compounds. Trends Parasitol. 2001;17:122-126.

    Not in our library10.1016/s1471-4922(00)01838-9

36. 36.

    Padua RA. Plasmodium chabaudi: genetics of resistance to chloroquine. Exp Parasitol. 1981;52:419-426.

    Not in our library10.1016/0014-4894(81)90101-6

37. 37.

    Poon H, Hensley K, Thongboonkerd V, Merchant M, Lynn B, Pierce W, et al. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice – a model of familial amylotrophic lateral sclerosis. Free Rad Biol Med. 2005;39:453-462.

    Not in our library10.1016/j.freeradbiomed.2005.03.030

38. 38.

    Price RN, Uhlemann A-C, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364:438-447.

    Not in our library10.1016/s0140-6736(04)16767-6

39. 39.

    Rathod PK, McErlean T, Lee P-C. Variations in frequencies of drug resistance in Plasmodium falciparum. Proc Natl Acad Sci USA. 1997;94:9389-9393.

    Not in our library10.1073/pnas.94.17.9389

40. 40.

    Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 2000;403:906-909.

    Not in our library10.1038/35002615

Cited by papers we hold 5

• Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda · 2022
  No notice
• Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome · 2018
  No notice
• Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription · 2011
  No notice
• Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum · 2009
  No notice
• Artemisinins: their growing importance in medicine · 2008
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.